BMJ Group retracts paper on COVID-19 vaccines and mortality featured in Senate hearing
A retracted study linking COVID-19 vaccines to excess deaths is stirring debate among scientists and politicians.
Evidence dossier
Intelligence passport
Measured timeline
-
Detected
-
Latest coverage observed
-
Peak measured velocity
-
Evidence threshold reached
-
Outcome review added
📍 How it ended
The BMJ Group retracted a 2024 study that had linked COVID-19 vaccines to excess deaths, citing misinformation. The paper, which had been featured in a Senate hearing, was retracted amid scientific criticism and concerns over its accuracy.
Epilogue added 88d ago, after coverage quieted.
What happened
- Velocity & Diffusion: Coverage exploded across 7 distinct news outlets with 7 published articles, achieving a live velocity of 5.
- Primary Driver: A retracted study linking COVID-19 vaccines to excess deaths is stirring debate among scientists and politicians.
- Predictive Outlook: Archynetys algorithmic models forecast this story will fade from trending status over the next 24 hours.
- Source Integrity: Verified strictly against primary headline reporting under zero-hallucination protocols.
The BMJ Group has retracted a 2024 paper that examined excess deaths during the COVID-19 pandemic. The paper had been featured in a Senate hearing. The BMJ Group cited misinformation as the reason for the retraction. The study had sparked controversy and fueled vaccine skepticism.
According to Scientific American, the paper was retracted over concerns about the accuracy of its findings. The Straits Times and ndtv.com noted that the study had faced significant scientific criticism. The BMJ Group's retraction notice did not specify the exact nature of the misinformation. The retraction has drawn attention to the political dimensions of the debate.
Retraction Watch noted that the paper had been featured in a Senate hearing, suggesting its findings had been used to support political arguments. The BMJ Group's decision to retract the paper underscores the ongoing scrutiny of scientific research in the public sphere.
Synthesized by Archynetys from the headlines below under a strict no-invention contract. Updated 88d ago.
Coverage (7)
-
Major COVID study that fueled vaccine skepticism retracted over ‘misinformation’Scientific American · 91d ago
-
BMJ Group retracts research published in 2024 on excess deathsBMJ Group · 91d ago
-
Controversial study on excess deaths during Covid-19 retractedThe Straits Times · 91d ago
-
COVID Excess Deaths Paper Retracted Over Misinformationmedpagetoday.com · 91d ago
-
-
A widely covered excess-death paper is retracted over misinformation concernsMedical Xpress · 91d ago
-
BMJ Group retracts paper on COVID-19 vaccines and mortality featured in Senate hearingRetraction Watch · 91d ago
Questions people are asking
What was the original study about?
The original study, published in 2024, examined excess deaths during the COVID-19 pandemic and suggested a link to COVID-19 vaccines.
Why was the study retracted?
The BMJ Group retracted the study due to concerns about misinformation in the paper.
How has the retraction been received?
The retraction has been noted by several outlets, including Scientific American, The Straits Times, and ndtv.com. The study had faced scientific criticism and had been featured in a Senate hearing, adding political dimensions to the debate.
The coverage curve
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
How do you expect this trend to evolve over the next 24 hours?
Cast your vote to register reader intelligence on the velocity and trajectory of this coverage.
Topics
From around our network
- Miller's Chief of Staff Job Needs No Senate Vote; Three DOJ Seats Do daybreakwire.com
Related trends
Google’s AlphaGenome 2 zooms in on the cellular roots of disease
Google DeepMind has launched AlphaGenome 2, a DNA model that predicts how genetic variants affect specific human cell types and states.
AI will soon master biology, unleashing new safety risks: Tencent AI chief
Tencent's AI chief warns that artificial intelligence will soon master biology, creating safety risks that could outweigh medical benefits.
Global return-on-investment of COVID-19 vaccines in the first year of the vaccination programme: A model-based economic evaluation
COVID-19 vaccines generated trillions in benefits, far exceeding their costs, but rich nations gained more
Health Canada approves Moderna’s combined COVID, flu shot for some
Health Canada approves Moderna’s combined COVID, flu shot for some adults.
Moderna Swings to Profit, Lifts Outlook as Covid-19 Vaccine Demand Stabilizes
Moderna swings to profit in Q3 2026 as Covid vaccine demand stabilizes and cancer pipeline gains traction.
What’s making you sick? Pittsburgh doctors explain the viruses circulating this fall
Pittsburgh doctors are helping patients distinguish between four major respiratory viruses circulating this fall.
Open prediction lab
Can you beat the machine?
Pick tomorrow's top trend, then compare your result with Archynetys's self-graded forecast.
📬 The daily trend digest
The world's top trends, once a day. No spam, one-click unsubscribe.